
14 Apr 2022
PANMURE: Oxford Biomedica : FY preview; 2021 was transformative – clarity on 2022+ requir
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
PANMURE: Oxford Biomedica : FY preview; 2021 was transformative – clarity on 2022+ requir
Oxford BioMedica plc (OXB:LON) | 652 -65.2 (-1.5%) | Mkt Cap: 783.1m
- Published:
14 Apr 2022 -
Author:
Dr Mike Mitchell | Julie Simmonds -
Pages:
7 -